SCHEMBL2316924

SCHEMBL2316924

CC(CI)(NC(=O)c1cccnc1)C(=O)Nc1nc(-c2ccccc2)c(Cc2ccccc2)s1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.52
ALDH1A1 P00352 2/20 0.52
KDM4E B2RXH2 1/20 0.52
POLB P06746 1/20 0.52
PLTP P55058 5/20 0.47
ADORA1 P30542 4/20 0.46
ADORA2A P29274 3/20 0.46
ADORA3 P0DMS8 3/20 0.46
RORC P51449 1/20 0.45
ROCK2 O75116 1/20 0.44
DGAT1 O75907 1/20 0.40
CHRM5 P08912 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
ADORA2B P29275 1/20 0.40
SCD O00767 1/20 0.40
DRD4 P21917 1/20 0.39
TSPO P30536 1/20 0.39
DRD3 P35462 1/20 0.39
TMEM97 Q5BJF2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2313698 0.90 PLTP (0.49) LMNAALDH1A1KDM4EPOLBPLTP
SCHEMBL2488862 0.89 LMNA (0.56) LMNAALDH1A1KDM4EPOLBPLTP
SCHEMBL2316402 0.85 PLTP (0.51) ALDH1A1KDM4EPLTPADORA1ADORA2A
SCHEMBL2318436 0.85 PLTP (0.50) ALDH1A1KDM4EPLTPADORA1ADORA2A
SCHEMBL2315059 0.85 PLTP (0.47) LMNAALDH1A1KDM4EPOLBPLTP
SCHEMBL2316605 0.84 ADORA1 (0.52) ALDH1A1PLTPADORA1ADORA2AADORA3
SCHEMBL2320700 0.84 PLTP (0.49) ALDH1A1PLTPADORA1ADORA2AADORA3
SCHEMBL2317599 0.84 PLTP (0.49) LMNAKDM4EPLTPADORA1ADORA3
SCHEMBL2314988 0.84 TRPV4 (0.54) KDM4EPLTPADORA1ADORA3RORC
SCHEMBL2319840 0.83 PLTP (0.48) ALDH1A1KDM4EPLTPADORA1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349484-A2 HETEROARYL DERIVATIVES AS DGAT1 INHIBITORS Novartis AG (CH) 2011-08-03 EP disclosed
WO-2010007046-A2 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2010-01-21 WO disclosed